Current Alzheimer Research
Title:Meet Our Editorial Board Member
Volume: 15 Issue: 1
Author(s): Jack T. Rogers
Affiliation:
Export Options
About this article
Cite this article as:
Rogers T. Jack , Meet Our Editorial Board Member, Current Alzheimer Research 2018; 15 (1) . https://dx.doi.org/10.2174/156720501501171221100417
DOI https://dx.doi.org/10.2174/156720501501171221100417 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
30
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Preparation and Evaluation of Novel Expandable Drug Delivery System with Captopril
Current Drug Therapy Mitochondria as a Therapeutic Target for Aging and Neurodegenerative Diseases
Current Alzheimer Research Mitochondrial VDAC1: Function in Cell Life and Death and a Target for Cancer Therapy
Current Medicinal Chemistry Is There A Pulse Wave Encephalopathy Component To Multiple Sclerosis?
Current Neurovascular Research A traditional Chinese Medicine, YXQN, Reduces Amyloid-induced Cytotoxicity by Inhibiting Aβ42 Aggregation and Fibril Formation
Current Pharmaceutical Design Pharmacophore Comparison and Development of Recently Discovered Long Chain Arylpiperazine and Sulfonamide Based 5-HT7 Ligands
Mini-Reviews in Medicinal Chemistry Folate Based Radiopharmaceuticals for Imaging and Therapy of Cancer and Inflammation
Current Pharmaceutical Design Developmental Synaptogenesis and General Anesthesia: A Kiss of Death?
Current Pharmaceutical Design Epinephrine and its Role in the Development of Obesity and Hypertension
Current Hypertension Reviews CypD: The Key to the Death Door
CNS & Neurological Disorders - Drug Targets Exploring N<sup>1</sup>-p-Fluorobenzyl-Cymserine as an Inhibitor of 5-Lipoxygenase as a Candidate for Type 2 Diabetes and Neurodegenerative Disorder Treatment
CNS & Neurological Disorders - Drug Targets Long-Term Protective Effects of Methamphetamine Preconditioning Against Single-Day Methamphetamine Toxic Challenges
Current Neuropharmacology Targeting Striatal Metabotropic Glutamate Receptor Type 5 in Parkinson’s Disease: Bridging Molecular Studies and Clinical Trials
CNS & Neurological Disorders - Drug Targets Treatments for Co-Occurring Depression and Substance Use in Young People: A Systematic Review
Current Drug Abuse Reviews Drug Metabolism and Individualized Medicine
Current Drug Metabolism Editorial [Hot Topic: Genome and Proteome Analyses of Autoimmune Diseases (Executive Editor: G. Neeck)]
Current Pharmaceutical Design Adherence to Cardiac Practice Guidelines in the Management of Non-ST-Elevation Acute Coronary Syndromes: A Systematic Literature Review
Current Cardiology Reviews Emerging Drug Target In Pancreatic Cancer: Placing Sirtuin 1 on the Canvas
Current Cancer Drug Targets BST-2 Expression in Human Hepatocytes is Inducible by All Three Types of Interferons and Restricts Production of Hepatitis C Virus
Current Molecular Medicine Viruses and Multiple Sclerosis
CNS & Neurological Disorders - Drug Targets